BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36070106)

  • 1. Glucose degradation products in peritoneal dialysis solution impair angiogenesis by dysregulating angiogenetic factors in endothelial and vascular smooth muscle cells.
    Aihara S; Nakano T; Torisu K; Kitazono T
    Clin Exp Nephrol; 2022 Dec; 26(12):1160-1169. PubMed ID: 36070106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glucose degradation product methylglyoxal induces immature angiogenesis in patients undergoing peritoneal dialysis.
    Nakano T; Kumiko T; Mizumasa T; Kuroki Y; Tsuruya K; Kitazono T
    Biochem Biophys Res Commun; 2020 May; 525(3):767-772. PubMed ID: 32147098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
    Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
    Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
    Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
    Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis.
    Inagi R; Miyata T; Yamamoto T; Suzuki D; Urakami K; Saito A; van Ypersele de Strihou C; Kurokawa K
    FEBS Lett; 1999 Dec; 463(3):260-4. PubMed ID: 10606733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High glucose dialysis solutions increase synthesis of vascular endothelial growth factors by peritoneal vascular endothelial cells.
    Seo MJ; Oh SJ; Kim SI; Cho KW; Jo I; Schaub T; Schilling H; Passlick-Deetjen J; Han DC
    Perit Dial Int; 2001; 21 Suppl 3():S35-40. PubMed ID: 11887852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis.
    Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis.
    Nakano T; Mizumasa T; Kuroki Y; Eriguchi M; Yoshida H; Taniguchi M; Masutani K; Tsuruya K; Kitazono T
    Perit Dial Int; 2020 Jan; 40(1):67-75. PubMed ID: 32063152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-mediated peritoneal neoangiogenesis in peritoneal dialysis.
    Shi Y; Hu Y; Cui B; Zhuang S; Liu N
    Perit Dial Int; 2022 Jan; 42(1):25-38. PubMed ID: 33823711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
    Hirahara I; Ishibashi Y; Kaname S; Kusano E; Fujita T
    Nephrol Dial Transplant; 2009 Feb; 24(2):437-47. PubMed ID: 18790810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis.
    Leung JC; Chan LY; Tam KY; Tang SC; Lam MF; Cheng AS; Chu KM; Lai KN
    Nephrol Dial Transplant; 2009 Feb; 24(2):458-69. PubMed ID: 18805993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.
    Terabayashi T; Ito Y; Mizuno M; Suzuki Y; Kinashi H; Sakata F; Tomita T; Iguchi D; Tawada M; Nishio R; Maruyama S; Imai E; Matsuo S; Takei Y
    Lab Invest; 2015 Sep; 95(9):1029-43. PubMed ID: 26121315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glucose degradation products, glucose-containing dialysate and icodextrin on AQP1 and eNOS expression in cultured endothelial cells.
    Lin X; Amore A; Loiacono E; Balegno S; Manniello D; Peruzzi L; Camilla R; Minieri V; Daprà V; Qian J; Coppo R
    J Nephrol; 2009; 22(1):117-22. PubMed ID: 19229826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal injury by methylglyoxal in peritoneal dialysis.
    Hirahara I; Kusano E; Yanagiba S; Miyata Y; Ando Y; Muto S; Asano Y
    Perit Dial Int; 2006; 26(3):380-92. PubMed ID: 16722033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2.
    Yuan J; Fang W; Ni Z; Dai H; Lin A; Cao L; Qian J
    Pediatr Nephrol; 2009 Jan; 24(1):163-70. PubMed ID: 18751736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor in dialysate in relation to intensity of peritoneal inflammation.
    Pawlaczyk K; Polubinska A; Numata N; Nakayama M; Pecoits-Filho R; Czekalski S; Lindholm B; Breborowicz A
    Int J Artif Organs; 2008 Jun; 31(6):535-44. PubMed ID: 18609506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylglyoxal and advanced glycation end-products promote cytokines expression in peritoneal mesothelial cells via MAPK signaling.
    Hong FY; Bao JF; Hao J; Yu Q; Liu J
    Am J Med Sci; 2015 Feb; 349(2):105-9. PubMed ID: 25581570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol Promotes Angiogenesis and Increases Cell Proliferation After Myocardial Ischemia-Reperfusion Injury Through a cAMP-Dependent Mechanism.
    Li J; Xiang X; Xu H; Shi Y
    Cardiovasc Eng Technol; 2019 Dec; 10(4):638-647. PubMed ID: 31625080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low glucose degradation products dialysis solution modulates the levels of surrogate markers of peritoneal inflammation, integrity, and angiogenesis: preliminary report.
    Kim YL; Do J; Park SH; Cho K; Park J; Yoon K; Cho DK; Lee EG; Kim IS
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S28-32. PubMed ID: 15012688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.